Purity Division: Precise Oxygen Supply – Application of Minnuo Medical PSA Oxygen Concentrators with 93% and 99.5% Purity

Introduction: The “Purity Code” of Medical Oxygen Supply – Why 93% and 99.5% Are Critical

In medical treatment, oxygen purity is directly linked to patients’ life safety and therapeutic effects. As an industry benchmark with over 20 years of expertise in PSA oxygen production technology, Jiangsu Minnuo Group develops dual-series medical oxygen concentrators with 93%±3% and 99.5% purity, complying with core standards including Chinese Pharmacopoeia and General Specification for Medical Molecular Sieve Oxygen Production Equipment (YY/T0298-1998). The seemingly small 6.5% purity gap corresponds to entirely different technical designs, clinical scenarios and application logics. This article unlocks the “purity selection guide” for medical PSA oxygen concentrators from three dimensions: technical principles, usage differences and application fields, helping medical institutions achieve the core goal of “precise, safe and efficient oxygen supply”.

I. Technical Core: “Birth Logic” of Two Purity Grades and Minnuo’s Technical Advantages

1. Purity Control Principle of Pressure Swing Adsorption (PSA) Technology

The core of a PSA oxygen concentrator is the selective adsorption of nitrogen by zeolite molecular sieves to separate oxygen and nitrogen. Minnuo medical PSA oxygen concentrators adopt a twin-tower alternating adsorption-desorption cycle. Under a high pressure of 0.6-0.8MPa, molecular sieves preferentially capture nitrogen (kinetic diameter 3.0Å) from air, enriching and producing oxygen (2.8Å). The difference between the two purity grades essentially stems from precise tuning of molecular sieve types, process parameters and system design:

• Approximately 93% purity: Adopting high-performance 13X zeolite molecular sieves, oxygen purity is stabilized at 90%-96% (residual gases are mainly argon and trace nitrogen) by optimizing the adsorption cycle (usually 60-90 seconds) and pressure control. It meets the minimum medical standard specified in YY/T0298-1998 and is the core choice for general clinical oxygen sources.
• 99.5% high purity: Equipped with imported lithium-based molecular sieves (LiLSX), combined with a three-stage purification module and vacuum desorption technology, the adsorption tower pressure is precisely controlled at 0.3-0.5MPa, the adsorption time is extended to 120 seconds, and residual argon is removed through countercurrent flushing. This pushes oxygen purity above 99.5%, satisfying the highest medical oxygen purity requirement in Chinese Pharmacopoeia.

2. Minnuo’s Purity Assurance System for Oxygen Concentrators

To ensure stable output of both purity grades, Minnuo has built a full-process quality control system:

• Raw material pretreatment: Equipped with three-stage air filtration and a freeze dryer, controlling the intake dew point below -40℃ to avoid moisture contamination of molecular sieves and ensure adsorption efficiency;
• Intelligent coordinated control system: PLC programmable controller adjusts the adsorption-desorption cycle in real time, matched with an online oxygen concentration monitor (accuracy ±0.1%). An audible and visual alarm and evacuation mechanism are automatically triggered when purity deviates from the set value;
• Modular design: 93% purity models adopt a standard twin-tower structure, while 99.5% models are upgraded to a “twin-tower + purification tower” combination. The service life of molecular sieves reaches 8,000-12,000 hours, reducing operation and maintenance costs by more than 30%.

II. Core Differences: “Usage Boundaries” Between 93% and 99.5% Purity

1. Clinical Adaptability: From “Basic Oxygen Therapy” to “Life Support”

Comparison Dimension	PSA Oxygen Concentrator with ~93% Purity	PSA Oxygen Concentrator with 99.5% Purity
Blood oxygen improvement efficiency	Suitable for mild to moderate hypoxia, patients with resting blood oxygen saturation (SPO₂) 88%-93%. Nasal cannula oxygen inhalation (2-5L/min) can quickly raise SPO₂ to above 95%	For severe hypoxia (SPO₂≤88%) or critically ill patients such as ARDS and traumatic shock. Stabilizes SPO₂ above 98% within 30 minutes, shortening rescue time
Treatment safety	No risk of oxygen toxicity for long-term use (more than 15 hours per day), especially suitable for home oxygen therapy of chronic patients such as COPD and pulmonary fibrosis	Usage duration must be controlled under doctor’s guidance (generally no more than 72 hours) to avoid alveolar damage caused by high-concentration oxygen. Safe use in mechanical ventilation is ensured through precise flow control (0.5-60L/min)
Equipment compatibility	Compatible with ordinary oxygen masks, nasal cannulas, and connectable to hospital central oxygen supply systems (covering 20-50 beds)	Compatible with precision equipment such as ventilators, anesthesia machines and neonatal incubators, supporting high-pressure oxygen supply scenarios in ICUs and operating rooms (pressure 0.4-0.6MPa)

2. Operating Costs and Applicable Scenarios

• 93% purity models: Lower energy consumption (0.45-0.6kWh per cubic meter of oxygen), equipment investment cost is 25%-30% lower than 99.5% models. Suitable for primary hospitals, community health service centers, rehabilitation institutions, etc., meeting daily oxygen therapy, postoperative rehabilitation and chronic disease care. For example, a community hospital adopts Minnuo MN-50 93% purity oxygen concentrator, with a daily oxygen supply of 120 cubic meters and an annual operation and maintenance cost of only 28,000 yuan, saving 60% of costs compared with bottled oxygen.
• 99.5% purity models: Slightly higher energy consumption (0.7-0.9kWh per cubic meter of oxygen) due to high-end molecular sieves and purification processes, but reduces mortality in critical illness treatment. For example, the ICU of a tertiary hospital is equipped with Minnuo MN-100H 99.5% purity oxygen concentrator. During the COVID-19 pandemic, it provided 24-hour stable oxygen supply for 20 critical beds, with an 85% improvement rate in patients’ oxygenation index, and a 40% faster response speed than traditional liquid oxygen supply.

3. Core Contraindications and Usage Restrictions

• 93% purity models are not applicable to: mechanical ventilation, neonatal high-concentration oxygen therapy, treatment of severe ARDS patients, otherwise treatment failure may occur due to insufficient oxygen partial pressure;
• 99.5% purity models are not recommended for: long-term home oxygen therapy for COPD patients. High-concentration oxygen may inhibit the respiratory center, cause carbon dioxide retention and increase the risk of disease deterioration.

III. Application Fields: “Purity Solutions” Precisely Matching Medical Scenarios

1. Approximately 93% Purity: The “Main Force” of General Clinical Oxygen Sources

(1) Primary Medical Care and Community Health Services

• Applicable scenarios: general wards, outpatient infusion rooms, chronic disease management centers;
• Core needs: temporary oxygen therapy for patients with colds, asthma, hypertension, etc., and rehabilitation care for diabetic foot, pressure ulcers, etc.;
• Minnuo solutions: MN-30/MN-50 oxygen concentrators, supporting simultaneous oxygen supply for 3-5 channels, equipped with moving wheels for flexible deployment in different departments, purity stabilized at 93%±2%, certified by European Pharmacopoeia 2455 standard.

(2) Home Oxygen Therapy and Rehabilitation Care

• Applicable groups: chronic disease patients such as COPD, pulmonary fibrosis, heart failure, those with resting SPO₂≤88% needing long-term oxygen therapy;
• Core advantages: Minnuo household 93% purity oxygen concentrators (MN-5/MN-10) are compact (floor area ≤0.3㎡), noise ≤45dB, supporting 1-10L/min flow adjustment, matched with intelligent blood oxygen monitoring module to synchronize data to doctors in real time, helping patients achieve “home precise oxygen therapy”. Clinical data shows that COPD patients using this model for a long time have a 62% increase in 5-year survival rate and a 40% reduction in hospitalizations.

(3) Elderly Care Institutions and Health Management Centers

• Applicable scenarios: nursing homes, health care communities, physical examination centers;
• Core value: providing preventive oxygen therapy for the elderly, relieving altitude sickness, sleep apnea syndrome and other symptoms. Minnuo modular oxygen concentrators can be flexibly expanded according to the number of beds (10-100), supporting remote operation and maintenance to reduce labor costs for elderly care institutions.

2. 99.5% Purity: The “Life Defense Line” for Critical Illness Treatment

(1) Core Departments of Tertiary Hospitals

• Applicable scenarios: ICU, operating room, neonatology department, emergency department;
• Core needs: mechanical ventilation, anesthetic gas mixing, neonatal intensive care, traumatic shock rescue;
• Minnuo solutions: MN-80H/MN-150H oxygen concentrators, adopting “twin-tower + purification tower” structure, purity stabilized at 99.5%±0.3%, moisture content ≤0.006%, complying with GB8982-2009 Oxygen for Medical and Aviation Breathing standard, connectable to hospital SCADA system for real-time monitoring and automatic adjustment of flow, pressure and purity. After using this model in the operating room of a tertiary hospital, the accuracy of anesthetic gas mixing is improved by 30%, and the incidence of surgical complications is reduced by 15%.

(2) Emergency Centers and Mobile Medical Care

• Applicable scenarios: ambulances, field rescue, disaster sites;
• Core advantages: Minnuo vehicle-mounted 99.5% purity oxygen concentrator (MN-20C) adopts lightweight design (weight ≤50kg), supports 12V/220V dual power supply, operates stably in -20℃~50℃ environment, provides high-concentration oxygen support for patients with traumatic shock and acute heart failure, filling the gap of high-purity oxygen supply in mobile emergency care.

(3) Special Medical Scenarios

• Applicable scenarios: hyperbaric oxygen chambers, hematology departments, respiratory intensive care units (RICU);
• Core value: 99.5% high-purity oxygen improves the treatment efficiency of hyperbaric oxygen chambers and accelerates rehabilitation of patients with carbon monoxide poisoning and ischemic encephalopathy; in hematology departments, high-purity oxygen improves oxygenation status of anemic patients and reduces blood transfusion needs. Minnuo customized high-purity oxygen concentrators support adjustable pressure of 0.8-1.0MPa to meet oxygen supply requirements of special medical equipment.

IV. Minnuo Group: Quality Assurance for Dual-Purity Oxygen Concentrators

1. Industry Certification and Standard Compliance

The full series of Minnuo medical PSA oxygen concentrators have passed ISO13485 medical device quality management system certification and CE certification. 93% purity models comply with European Pharmacopoeia 2455 standard, and 99.5% models meet the requirements of Chinese Pharmacopoeia. All products have passed 1,000 hours of continuous operation testing with purity fluctuation ≤±0.5%, ensuring safe and reliable clinical use.

2. Customized Solutions and Services

• Preliminary planning: Provide “purity + flow” customized plans according to the number of hospital beds, department needs and site conditions. For example, recommend 93% purity modular units for primary hospitals and 99.5% purity redundant systems for ICUs of tertiary hospitals;
• Installation and operation maintenance: More than 200 service outlets nationwide, providing on-site installation and commissioning within 72 hours, 2 free inspections per year, and lifelong maintenance of molecular sieves;
• Intelligent upgrade: Support remote monitoring, fault early warning and data traceability, connectable to hospital HIS system to realize digital oxygen supply management.

3. Customer Case Witnesses

• A county people’s hospital (Grade II Class A): Adopts Minnuo MN-80 93% purity oxygen concentrator, covering 80 beds, operates without failure for 3 years, saving 120,000 yuan in annual oxygen supply costs;
• A provincial emergency center: Equipped with 20 Minnuo MN-20C vehicle-mounted 99.5% purity oxygen concentrators, providing high-concentration oxygen for more than 300 seriously injured people in earthquake rescue, increasing the rescue success rate by 25%;
• A high-end nursing home: Installs Minnuo MN-50 93% purity oxygen concentrator, providing 24-hour oxygen therapy for 120 elderly people, with 98% elderly satisfaction.

Conclusion: Choose the Right Purity for More Precise and Safer Oxygen Supply

Medical oxygen supply is a critical matter, and purity selection is the key. Minnuo PSA oxygen concentrators with approximately 93% purity are ideal choices for primary medical care and home oxygen therapy with high cost performance and wide adaptability. 99.5% high-purity models serve as the “life backing” for critical illness treatment with extreme purity control and stability. Committed to the mission of “Empowering Medical Care with Technology, Guarding Lives Precisely”, Jiangsu Minnuo Group provides medical oxygen solutions meeting the needs of medical institutions at all levels through continuous technological innovation and customized services.

Whether you are a procurement officer of a primary hospital or an equipment maintenance engineer of a tertiary hospital, Minnuo will provide one-on-one purity selection guidance to maximize the value of each oxygen concentrator. Choose Minnuo, choose the reassuring guarantee of “precise purity, safe oxygen supply”!